Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,245 | 13,202 | 45,947 | 52,179 | 15,797 |
| Marketable Securities | 35,367 | 52,638 | 79,947 | 82,508 | 82,143 |
| Receivables | 622 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 4,636 | 0 | 0 |
| TOTAL | $53,407 | $68,150 | $133,271 | $136,117 | $99,026 |
| Non-Current Assets | |||||
| PPE Net | 532 | 561 | 586 | 614 | 645 |
| Investments And Advances | 314,590 | 198,983 | 95,660 | 82,905 | 59,142 |
| Other Non-Current Assets | 1,114 | 1,153 | 1,347 | 857 | 2,871 |
| TOTAL | $316,236 | $200,697 | $97,593 | $84,376 | $62,658 |
| Total Assets | $369,643 | $268,847 | $230,864 | $220,493 | $161,684 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,508 | 8,521 | 6,853 | 4,862 | 2,193 |
| TOTAL | $10,731 | $10,563 | $19,086 | $6,119 | $3,693 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,710 | 1,471 | 1,353 | 986 | 1,236 |
| Other Non-Current Liabilities | 686 | 731 | 854 | 633 | 712 |
| TOTAL | $41,439 | $20,008 | $12,034 | $12,044 | $4,408 |
| Total Liabilities | $52,170 | $30,571 | $31,120 | $18,163 | $8,101 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,597 | 40,926 | 40,446 | 39,802 | 41,004 |
| Common Shares | 495 | 491 | 472 | 490 | 491 |
| Retained earnings | -6,965 | -85,121 | -123,436 | -122,575 | -170,970 |
| Other shareholders' equity | 0 | 0 | 0 | -952 | -946 |
| TOTAL | $317,473 | $238,276 | $199,744 | $202,330 | $153,583 |
| Total Liabilities And Equity | $369,643 | $268,847 | $230,864 | $220,493 | $161,684 |